IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $449 | -85.8% | 98,663 | -78.1% | 0.00% | -84.6% |
| Q2 2023 | $3,167 | +95.4% | 449,900 | +77.3% | 0.03% | +8.3% |
| Q4 2022 | $1,621 | -99.8% | 253,733 | +260.5% | 0.02% | +166.7% |
| Q3 2022 | $674,000 | -38.8% | 70,379 | -29.5% | 0.01% | -35.7% |
| Q2 2022 | $1,102,000 | -52.2% | 99,779 | -27.9% | 0.01% | -51.7% |
| Q1 2022 | $2,304,000 | +681.0% | 138,355 | +793.8% | 0.03% | +866.7% |
| Q4 2021 | $295,000 | -59.8% | 15,479 | -48.0% | 0.00% | -70.0% |
| Q3 2021 | $734,000 | -46.4% | 29,754 | -43.5% | 0.01% | -33.3% |
| Q2 2021 | $1,370,000 | -35.3% | 52,652 | +15.3% | 0.02% | -28.6% |
| Q4 2020 | $2,119,000 | +323.8% | 45,671 | +200.9% | 0.02% | +110.0% |
| Q3 2020 | $500,000 | -79.0% | 15,176 | -82.5% | 0.01% | -83.9% |
| Q2 2020 | $2,386,000 | – | 86,920 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |